COVID-19 infection in children with cancer and stem cell transplant recipients in Turkey: A nationwide study

dc.contributor.authorKebudi, Rejin
dc.contributor.authorKurucu, Nilgün
dc.contributor.authorTuğcu, Deniz
dc.contributor.authorHacısalihoğlu, Sadan
dc.contributor.authorFışgın, Tunç
dc.contributor.authorOcak, Süheyla
dc.contributor.authorKara, Ateş
dc.contributor.authorBozkurt, Ceyhun
dc.contributor.authorInce, Dilek
dc.contributor.authorAras, Seda
dc.contributor.authorAycicek, Ali
dc.contributor.authorAksoy, Basak Adakli
dc.contributor.authorKaradas, Nihal
dc.contributor.authorOzturk, Gulyuz
dc.contributor.authorOrhan, Mehmet Fatih
dc.contributor.authorAtaseven, Eda
dc.contributor.authorAkbayram, Sinan
dc.contributor.authorYilmaz, Ebru
dc.contributor.authorTufekci, Ozlem
dc.contributor.authorVural, Sema
dc.contributor.authorAkyay, Arzu
dc.contributor.authorAyhan, Aylin Canbolat
dc.contributor.authorKilic, Suar
dc.contributor.authorUzel, Veysiye Hulya
dc.contributor.authorDuzenli, Yeter
dc.contributor.authorAcipayam, Can
dc.contributor.authorElli, Murat
dc.contributor.authorTanyeli, Atilla
dc.contributor.authorKarakas, Zeynep
dc.contributor.authorSomer, Ayper
dc.contributor.authorKara, Ates
dc.date.accessioned2021-05-15T11:33:15Z
dc.date.available2021-05-15T11:33:15Z
dc.date.issued2021
dc.departmentTıp Fakültesi, Pediatrik Hematoloji Pediatrik Kök Hücre Nakli Anabilim Dalıen_US
dc.descriptionAksoy, Basak Adakli/0000-0001-8338-2101; Ozdemir, Nihal/0000-0002-3204-4353
dc.description.abstractAdults with cancer are reported to have a higher risk for coronavirus disease (COVID-19) infection and more severe disease and mortality than the general population.1,2 Although children seem to be at a lower risk for COVID-19 than adults,3–5 data specifically addressing children with cancer are limited.6–12 We conducted a retrospective, multicenter, cross-sectional study on behalf of the Turkish Pediatric Hematology Society (TPHD) and Turkish Pediatric Oncology Group (TPOG) Society to analyze the characteristics of COVID-19 in all patients with cancer and stem cell transplant (SCT) recipients in all centers in Turkey, during March 11-May 31, 2020. Approval for the study was obtained by Turkish Ministry of Health (MoH), Istanbul University COVID Scientific Research Committee, and Istanbul University Ethics Committee. The study was carried out through the analysis of a questionnaire with 62 questions, which was sent to all members of the TPOG and TPHD Societies working in all 66 pediatric hematology/oncology departments in university, state, and private hospitals in Turkey. All replied and 53 patients were reported from the 24 centers.en_US
dc.identifier.doi10.1002/pbc.28915
dc.identifier.issn1545-5009
dc.identifier.issn1545-5017
dc.identifier.issue6en_US
dc.identifier.pmid33538100
dc.identifier.scopus2-s2.0-85100509840
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1002/pbc.28915
dc.identifier.urihttps://hdl.handle.net/20.500.12939/111
dc.identifier.volume68en_US
dc.identifier.wosWOS:000614296900001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorBozkurt, Ceyhun
dc.language.isoen
dc.publisherWileyen_US
dc.relation.ispartofPediatric Blood & Cancer
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectTurkeyen_US
dc.subjectChildren With Canceren_US
dc.subjectCell Transplant Recipientsen_US
dc.titleCOVID-19 infection in children with cancer and stem cell transplant recipients in Turkey: A nationwide study
dc.typeLetter

Dosyalar